CAR T-cell Therapy for Lymphoma Patients in Manitoba
Date/Time:
Thursday, June 20th, 2024
4:00pm EST
Description:
CAR T-cell therapy is a novel treatment option for certain lymphoma patients who have relapsed or have a refractory response to multiple lines of treatment. In this webinar, Dr. Menard will delve into the revolutionary CAR T-cell therapy, discussing its applications, efficacy, availability and accessibility specifically for patients within Manitoba.
Speaker:
Dr. Chantalle Menard
Speaker Bio:
Dr. Menard is a hematologist at CancerCare Manitoba with a special interest in lymphoma, leukemia and bone marrow transplantation. Dr. Menard completed her medical degree and post-graduate training in Internal Medicine and Hematology at the University of Manitoba, as well as a fellowship in Advanced Training in Hematologic Malignancies. Dr. Menard obtained a Master of Science in Healthcare Quality through Queens University, and uses her knowledge in Quality Improvement to enhance care delivery and reduce diagnostic delays for patients with cancer in Manitoba. She provides clinical services within the Lymphoma, Leukemia and Bone Marrow Transplant Disease Site Groups.
